ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ETX E-therapeutics Plc

9.75
-0.20 (-2.01%)
Last Updated: 10:02:03
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
E-therapeutics Plc LSE:ETX London Ordinary Share GB00B2823H99 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -2.01% 9.75 9.55 10.50 9.75 9.75 9.75 61,764 10:02:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 475k -8.27M -0.0142 -6.87 56.92M

e-Therapeutics plc Holding(s) in Company (0203U)

12/01/2017 10:38am

UK Regulatory


TIDMETX TIDMAV.

RNS Number : 0203U

e-Therapeutics plc

12 January 2017

 
 For filings with the FCA 
  include the annex 
 For filings with issuer exclude 
  the annex 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                       e-Therapeutics plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------------  ------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
--------------------------------------------------------------------  ---------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
--------------------------------------------------------------------  ---------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
--------------------------------------------------------------------  ---------------------------------- 
 An event changing the breakdown of voting rights 
--------------------------------------------------------------------  ---------------------------------- 
 Other (please 
  specify): 
-----------------------------------------------------------  -------  ---------------------------------- 
 3. Full name of person(s)                                      Aviva plc & its subsidiaries 
  subject to the 
  notification obligation: 
  (iii) 
-------------------------------------------------------------  ----------------------------------------- 
 4. Full name of shareholder(s)                                 Registered Holder: 
  (if different from 3.):(iv) 
 
                                                                BNY Norwich Union Nominees 
                                                                Limited 3,309,498* 
 
                                                                Chase (GA Group) Nominees 
                                                                Limited 37,607,733* 
 
                                                                * denotes direct interest 
 
                                                                Chase Nominees Limited 1,625,637 
-------------------------------------------------------------  ----------------------------------------- 
 5. Date of the transaction                                     10 January 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-------------------------------------------------------------  ----------------------------------------- 
 6. Date on which issuer                                        11 January 2017 
  notified: 
-------------------------------------------------------------  ----------------------------------------- 
 7. Threshold(s) that is/are                                    16% to 15% Change at Combined 
  crossed or                                                     Interest Level 
  reached: (vi, vii) 
-------------------------------------------------------------  ----------------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type         Situation previous              Resulting situation after the 
  of                 to the triggering               triggering transaction 
  shares             transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-----------------  ------------------------------  ----------------------------------------------------------- 
                    Number             Number       Number         Number of                 % of voting 
                     of                 of           of shares      voting                    rights (x) 
                     Shares             Voting                      rights 
                                        Rights 
-----------------  -----------------  -----------  -------------  ------------------------  ------------------ 
                                                    Direct         Direct       Indirect     Direct   Indirect 
                                                                    (xi)         (xii) 
-----------------  -----------------  -----------  -------------  -----------  -----------  -------  --------- 
 Ordinary 
  Shares 
 
 
  GB00B2823H99      44,073,702         44,073,702   42,542,868     40,917,231   1,625,637    15.24%    0.61% 
                   -----------------  -----------  -------------  -----------  -----------  -------  --------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration         Exercise/                   Number of voting          % of voting 
  financial          date               Conversion                  rights that               rights 
  instrument         (xiii)             Period (xiv)                may be 
                                                                    acquired if 
                                                                    the 
                                                                    instrument 
                                                                    is 
                                                                    exercised/ 
                                                                    converted. 
-----------------  -----------------  --------------------------  ------------------------  ------------------ 
 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
 42,542,868                15.85% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------------------------ 
                         The voting rights are managed and controlled by Aviva 
                         Investors Global Services Limited, with the following 
                                            chain of controlled undertakings:- 
 
                                      Aviva Investors Global Services Limited: 
                                               *    Aviva plc (Parent Company) 
 
 
                    *    Aviva Group Holdings Limited (wholly owned subsidiary 
                                                                 of Aviva plc) 
 
 
                           *    Aviva Investors Holdings Limited (wholly owned 
                                   subsidiary of Aviva Group Holdings Limited) 
 
 
                    *    Aviva Investors Global Services Limited (wholly owned 
                               subsidiary of Aviva Investors Holdings Limited) 
 
 Proxy Voting: 
------------------------------------------------------------------------------ 
 10. Name of the proxy holder:                  See Section 4 
---------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
---------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
---------------------------------------------  ------------------------------- 
 
 
  13. Additional information:                    Figures are based on the 
                                                 total number of voting rights 
                                                 of 268,426,042 as per the 
                                                 Company's Issue of Equity 
                                                 Announcement of 4 January 
                                                 2017. 
---------------------------------------------  ------------------------------- 
 14. Contact name:                              Neil Whittaker, Aviva plc 
---------------------------------------------  ------------------------------- 
 15. Contact telephone number:                      01603 684420 
---------------------------------------------  ------------------------------- 
 
 

The company news service from the London Stock Exchange

END

HOLEAEFAFDSXEFF

(END) Dow Jones Newswires

January 12, 2017 05:38 ET (10:38 GMT)

1 Year E-therapeutics Chart

1 Year E-therapeutics Chart

1 Month E-therapeutics Chart

1 Month E-therapeutics Chart

Your Recent History

Delayed Upgrade Clock